Clinical evaluation of measurement of Toll-like receptor 2 and CD64 receptor on peripheral blood mononuclear cell in pneumonia patients
Not Applicable
- Conditions
- Community-acquired pneumonia, Hospital-acquired pneumonia, Healthcare-associated pneumonia
- Registration Number
- JPRN-UMIN000005512
- Lead Sponsor
- agasaki evaluation organization for clinical interventions
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
The following patients were excluded from the study: (1) patients received any antibiotics prior to this study, (2) patients received immunosuppressive agents, (3) patients with taking steroids (more than 10mg/day as predonisolone), (4) patients who were not considered as participant by attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method